Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WaferGen to Present at the Rodman and Renshaw Annual Global Investment Conference
WaferGen to Present at the Rodman and Renshaw Annual Global Investment Conference
Sep. 3, 2009 (PR Newswire) --
FREMONT, Calif., Sept. 3 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced that Mr. Alnoor Shivji, President and Chief Executive Officer, will deliver a corporate presentation at the Rodman & Renshaw Annual Global Investment Conference. The conference will be held September 9-11, 2009, at the New York Palace Hotel in New York.
Mr. Shivji's presentation will take place at 4:30 p.m. on Thursday, September 10th in the Fahnestock Salon. The presentation will include an overview of the company's SmartChip(TM) system, which has undergone successful alpha testing at The University of Pittsburg Medical Center (UPMC). As a result of the positive data, WaferGen has initiated multiple collaborations with academic research centers in the US and Europe. A live webcast of the presentation will be available at www.wafergen.com and will be archived for 90 days.
About WaferGen
WaferGen Biosystems, Inc. is a leader in the development, manufacture and sale of state-of-the-art systems for gene expression, genotyping, cell biology and stem cell research for the life science and pharmaceutical industries. The company is actively developing its SmartChip(TM) product for the gene expression and genotyping markets. SmartChip(TM) is being developed as the first whole genome, high throughput gene expression real-time polymerase chain reaction (PCR) platform and promises to deliver significant speed and cost advantages to researchers in the gene expression and genotyping markets.
Forward-Looking Statements
This press release may contain certain "forward-looking statements". Such statements include statements relating to the recent strengthening of the leadership team of the company and other statements relating to future events or to the company's future financial performance and are not historical facts, including statements which may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words.
Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the control of the company. Actual results may differ materially from the expectations contained in the forward-looking statements. Factors that may cause such differences include the risks that: (i) the company may be unsuccessful in commercially developing its products or in achieving market acceptance of new and relatively unproven technologies; (ii) the company will need to raise additional capital to meet its business requirements in the future and the company may not be able to do so on reasonable terms or at all; (iii) the company's proprietary intellectual property rights may not adequately protect its products and technologies; and (iv) the company expects intense competition in its target markets, including from companies that have much greater resources than the company, and there can be no assurance that the company will be able to compete effectively. More detailed information about the company and the risk factors that may affect the realization of forward-looking statements is set forth in the company's filings with the Securities and Exchange Commission, including the company's Annual Report on Form 10-K for the year ended December 31, 2008 and the company's Quarterly Reports on Form 10-Q for the quarters ended March 31 and June 30, 2009. Investors and security holders are urged to read this document free of charge on the SEC's web site at www.sec.gov. The company does not undertake to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
Contact:Michelle Schonemann510-360-6111michelle.schonemann@wafergen.com
SOURCE WaferGen Biosystems, Inc.
In due time. As financing comes through the company will be able to start up production, which is huge for a 9 month old company!! New CEO with skills in the oil industry!
"The closing of this final partnership under the VIII Drilling Program means Aztec has raised approximately $4 million in drilling funding over the last five (5) months in a very difficult market. We are very pleased with those results in this present investment environment and the vote of confidence given Aztec. Our firm continues to grow and expand while many others are shrinking or going out of business; and, we feel all the hard work, attention to detail and performance is paying off for our firm and its investors," stated Waylan R. Johnson, President, Aztec Oil & Gas, Inc.
I saw that. This honey is bout to burst imo
Eddie, I called the place you assume in your post that is working Treaty. They said they have never heard of this company and have no knowledge of any company doing as you claim. Either your post was intentionally misleading or your information was incorrect.
Hi mick thanks for stopping by, I appreciate the charts!! I grew up in chitown and now live in south barrington.
Hopefully we can close the gap in the am
Well, that BLOWS. This stock could really move imo
Deltacom Upgrades Simpli-Business(SM) Integrated Communications Service to Deliver Enhanced Auto Attendant and Auto Call Distribution Capabilities for Business Customers in the Southeast
Deltacom Upgrades Simpli-Business(SM) Integrated Communications Service to Deliver Enhanced Auto Attendant and Auto Call Distribution Capabilities for Business Customers in the Southeast
Sep. 2, 2009 (PR Newswire) --
HUNTSVILLE, Ala., Sept. 2 /PRNewswire-FirstCall/ -- ITC^DeltaCom, Inc. (OTC: ITCD.OB), a leading provider of integrated communications services to customers in the southeastern United States, today announced the enhancement of its Simpli-Business(SM) service with the incorporation of NEC's UNIVERGE SV8100 Communications Server that establishes an Internet Protocol (IP) based platform that immediately increases functionality and provides an efficient platform for future IP-based applications. Simpli-Business now supports remote access for phone system management, including the ability to make changes to integrated auto attendant features and auto call distribution and also delivers multimedia voice to e-mail functionality.
"Deltacom stands behind its commitment to drive efficiencies for our business customers in these tough economic times," said Tony Tomae, Deltacom's Executive Vice President of Sales and Marketing. "The ability to remotely update call distribution settings, manage call treatment from a PC, route calls to virtual extensions like mobile devices or alternate locations, and receive voicemail via e-mail files are all time saving benefits that add up for our customers."
Simpli-Business is a comprehensive solution that bundles local and long distance voice, data and multi-media communications services with an IP-based phone system and desk top terminals, in addition to eco-friendly multi-functional printers that print, copy, scan and fax. Simpli-Business enables Deltacom's business customers to enjoy a total communications solution, provided by a single vendor with no capital investment. Simpli-Mobile(SM) services are also available to provide a more robust solution that keeps business employees connected while working remotely or traveling.
ABOUT ITC^DELTACOM, INC.
ITC^DeltaCom, Inc., headquartered in Huntsville, Alabama, provides, through its operating subsidiaries, integrated telecommunications and technology services to businesses and other communications providers in the southeastern United States. ITC^DeltaCom has a fiber optic network spanning approximately 15,965 route miles, including more than 12,020 route miles of owned fiber, and offers a comprehensive suite of voice and data communications services, including local, long distance, broadband data, Internet connectivity, wireless voice and data services, and customer premise equipment. ITC^DeltaCom is one of the largest competitive telecommunications providers in its primary eight-state region. For more information, visit ITC^DeltaCom's web site at www.deltacom.com.
Investor Contact: Media Contact:Richard E. Fish Lisa PowellChief Financial Officer, Director Corporate Communications,Deltacom Deltacom256-382-3827 256-382-5976richard.fish@deltacom.com lisa.powell@deltacom.com
SOURCE ITC^DeltaCom, Inc.
Source: PR Newswire (September 2, 2009 - 2:00 PM EDT)
Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinson's Disease
Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinson's Disease
Sep. 2, 2009 (World Stock Wire) --
Woodlands, TX - (WORLD STOCK WIRE) - September 2, 2009 -- Transgenomic, Inc. (OTCBB:TBIO) (OTC Bulletin Board: TBIO) and Power3 Medical Products (OTCBB:PWRM) , Inc. (OTC Bulletin Board: PWRM) today announced the advance on-line publication of a clinical research paper entitled "Abnormal Serum Concentrations of Proteins in Parkinson's Disease" in the scientific journal Biochemical and Biophysical Research Communications. The study demonstrates the usefulness of a protein biomarker panel to distinguish Parkinson's disease (PD) patients from age-matched normal controls independent of the severity of symptoms, using clinical blood serum samples.
The analytic technology forms the basis for the NuroPro(R)PD test for PD being commercialized by Transgenomic as per a licensing/collaboration agreement with Power3 Medical signed in early 2009. The publication of the peer-reviewed article is a significant validation milestone in the ongoing clinical development of the NuroProPD diagnostic assay.
The article describes the use of analytically validated quantitative 2D gel electrophoresis to identify protein biomarkers for diagnosing PD using serum from routinely collected blood samples. 57 protein biomarkers, which had been discovered using retrospective blood serum samples from various neurodegenerative diseases, were then applied specifically to PD in a prospective clinical investigation using freshly collected blood serum from PD patients and age-matched normal controls. A multi-variate statistical method, stepwise linear discriminant analysis, selected a combination of 21 of the biomarkers as optimal to distinguish PD patients from controls. When applied to the PD samples, the 21-protein set had sensitivity of 93.3% (52 of 56 PD correctly classified) and specificity of 92.9% (28 of 30 controls correctly classified); 15 of 15 patients with mild and 28 of 30 with moderate to severe symptoms were correctly classified, as were all 6 PD samples from an independent site.
"We are enthusiastic about the acceptance of our paper in this established peer-reviewed scientific journal. It represents independent external validation of the clinical data, and so increases the confidence that we have in NuroProPD to be a meaningful tool for the diagnosis of Parkinson's disease, especially early in its course," said Craig Tuttle, CEO of Transgenomic. "We are completing the clinical validation of the assay in our CLIA-certified molecular testing laboratory and will be launching the assay in the very near future."
"In the U.S., there are an estimated 1.5 million individuals with Parkinson's disease. Unfortunately, by the time patients are given a probable diagnosis, many have already suffered substantial and irreparable brain damage, rendering treatment less effective," said Dr. Ira Goldknopf, President and CSO of Power3 Medical and lead author on the paper. "The fact that these results were obtained using fresh blood serum, in the same way that the test will be performed in a clinical diagnostic setting, provides further support for their robustness and their commercial value."
Clinical investigators in the study were Dr. Katerina Markopoulou of the University of Thessaly, Greece, Drs. Marwan Sabbagh and Holly Shill of Banner Sun Health Research Institute, Sun City, Arizona, and Dr. Stanley Appel of the Texas Methodist Health System, Houston.
About Transgenomic, Inc.
Transgenomic, Inc. (OTC BB: TBIO.OB, www.transgenomic.com ) is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis, providing products and services in DNA mutation detection and discovery for clinical research, clinical molecular diagnostics and pharmacogenomics analyses. Its product offerings include the WAVE(R) Systems and associated consumables specifically designed for use in genetic variation detection and single- and double-strand DNA/RNA analysis and purification. With broad applicability to genetic research, over 1,450 systems have been shipped to customers in more than 30 countries. The SURVEYOR(R) Mutation Detection Kits and SURVEYOR Check-It Kit provide reagents and protocols for high sensitivity detection of mutations in DNA. In addition, HANABI automated chromosome harvesting systems improve laboratory productivity with consistent quality compared to manual methods for cytogenetic analyses. Service offerings include the Transgenomic Molecular Laboratory, which provides reference laboratory services specializing in molecular diagnostics including Mitochondrial Disorders, Oncology and Hematology, Molecular Pathology and Inherited Diseases. Transgenomic Pharmacogenomic Services is a CRO for pharmacogenomic, translational research and clinical trials.
About Power3 Medical Products, Inc.
Power3 Medical Products, Inc. (OTCBB: PWRM, www.power3medical.com ) is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3 Medical operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas.
Cautionary Statements
Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements include, but are not limited to, those with respect to management's current views and estimates of future economic circumstances, industry conditions, company performance and financial results, including the ability of the Company to grow its involvement in the diagnostic products and services markets. The known risks, uncertainties and other factors affecting these forward-looking statements are described from time to time in reports to the Securities and Exchange Commission. Any change in such factors, risks and uncertainties may cause the actual results, events and performance to differ materially from those referred to in such statements. Accordingly, the company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained in this press release
Helen R. Park, M.S., hpark@power3medical.com
Power3 Medical Products, Inc.
3400 Research Forest Drive
Suite B2-3
Woodlands, TX 77381
USA
Phone: 281-466-1600
Fax: 281-466-1481
Note: The following news is from Power3 Medical Products, Inc., and World Stock Wire, Inc. is not liable for the contents of this news
I just saw news for this stock on otcbb.com
Aztec Announces Closing of Most Recent Drilling Partnership
Aztec Announces Closing of Most Recent Drilling Partnership
Sep. 2, 2009 (GlobeNewswire) --
HOUSTON, Sept. 2, 2009 (GLOBE NEWSWIRE) -- Aztec Oil & Gas, Inc. (PinkSheets:AZGS) announced today the closing, on August 31, of its most recent partnership under its Aztec VIII Oil & Gas Drilling Program. The partnership, "Aztec VIIIC Oil & Gas LP", closed with approximately $1,750,000 of funding and will focus on shallow oil drilling in Texas. Aztec Oil & Gas, Inc., through its wholly-owned subsidiary, Aztec Energy, LLC, will retain thirty percent (30%) ownership and will act as the Managing General Partner. Another wholly-owned subsidiary, Aztec Drilling & Operating, LLC, will serve as the Partnership's drilling company and operator.
"The closing of this final partnership under the VIII Drilling Program means Aztec has raised approximately $4 million in drilling funding over the last five (5) months in a very difficult market. We are very pleased with those results in this present investment environment and the vote of confidence given Aztec. Our firm continues to grow and expand while many others are shrinking or going out of business; and, we feel all the hard work, attention to detail and performance is paying off for our firm and its investors," stated Waylan R. Johnson, President, Aztec Oil & Gas, Inc.
About Aztec Oil & Gas, Inc.
Aztec is an oil and gas exploration, development and production company focusing on Texas and numerous areas throughout the U.S. Its interests are highly diversified as exemplified by its corporate participation in two Deep Lake wells in Cameron Parish, Louisiana ranging from 13,600 feet to 14,300 feet in depth versus its corporate participation in three shallow gas wells in Oklahoma of which two are conventional wells, and the third is a horizontal, Coal Bed Methane (CBM) well.
In 2006 Aztec entered the sponsored drilling program industry and undertook three small, very limited annual drilling partnerships in Appalachia. Drilling in Appalachia was recommended to Aztec by several broker dealers and a wholesaler, supposedly, because many broker dealers were familiar with programs from the area. Aztec intentionally limited its sponsored drilling programs over the subject three years in order to become fully familiar with the nuances of the sponsored drilling program industry before expanding to the Company's full capabilities. In the summer of 2008, due to what it felt was a questionable outlook for shallow gas drilling in the Appalachian region; Aztec decided to discontinue any natural gas drilling in Appalachia and announced such publicly at a subsequent industry conference.
Aztec focused all drilling in 2009 on Texas and adjoining states. In addition to the initial, three existing small Appalachian drilling partnerships mentioned above; Aztec recently sponsored and closed its VIII A and B partnerships. The sixth drilling partnership, Aztec VIII C Oil & Gas LP, referenced in the above press release, will also focus on drilling in Texas with the first well estimated to begin drilling in the next several weeks. Aztec Energy LLC, a wholly-owned subsidiary of Aztec, acts as Managing General Partner of all drilling partnerships and another wholly-owned Aztec subsidiary, Aztec Drilling & Operating, LLC, is the turnkey drilling contractor and operator. Aztec owns a 30% interest in all of its drilling partnerships. In general clarification of its activities, Aztec sponsors low risk, development drilling programs which include significant tax benefits, all of which are sold through FINRA Registered Broker Dealers and Registered Investment Advisors to Accredited Investors. Aztec's drilling programs focus on shallow oil drilling, are very unique and also incorporate a sophisticated exit strategy for investors.
For more information on Aztec Oil & Gas, Inc. please visit http://www.aztecoil-gas.com.
This release/announcement is neither an offer to sell nor a solicitation of an offer to buy securities or participations. This release/document contains certain statements, estimates, and forecasts with respect to future performance and events. All statements other than statements of historical fact included in this release/document, the Memorandum, or the Aztec website, including statements regarding future performance of events, are forward-looking statements. All such forward-looking statements are based on various underlying assumptions and expectations and are subject to risks and uncertainties which could cause actual events to differ materially from those expressed in the forward-looking statements. As a result, there can be no assurance that the forward-looking statements included in this release, the Memorandum, or the Aztec Website will prove to be accurate or correct. In light of these risks, uncertainties and assumptions, the future performance or events described in the forward-looking statements in this release/document, the Memorandum, or the Aztec Website might not occur. Accordingly, investors should not rely upon forward-looking statements as a prediction of actual results. Also, the price Aztec Oil & Gas, Inc. and the other parties involved in any properties receive for the oil and natural gas produced on their properties may be less than quoted NYMEX prices at any given time. Aztec does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events, subsequent circumstances or otherwise.
CONTACT: Phoenix IR Associates Investor Relations Tony Drake (281) 579-1602 investor@aztecoil-gas.com
Treaty Energy Corporation Announces Corporate Headquarters Moved to Houston, Texas
HOUSTON, TX -- (Marketwire) -- 08/17/09 -- Treaty Energy Corporation (OTCBB: TECO), a growth-oriented energy company in the oil and gas industry, today announced it has relocated its Corporate Headquarters to Houston from Abilene Texas effective August 15, 2009.
Treaty Energy's Chairman and CEO Randall Newton stated, "Treaty is in the process of acquiring oil wells in proven fields in Texas, Pennsylvania, Louisiana, West Virginia, Arkansas, and Tennessee. Because of our anticipated rapid growth, the Company made the decision to establish its main corporate office in Houston, which is the must-be location for any emerging oil and gas company."
The new offices are located in the Lyric Center in Downtown Houston's Theater District, sharing common space with a well known law firm, part of which deals in the oil and gas business.
About Treaty Energy Corporation
Treaty is engaged in the acquisition, development and production of oil and natural gas, primarily in the West Texas Permian Basin, but may expand this scope if suitable opportunities come to Treaty's attention. Treaty acquires and develops petroleum productive properties, many of which have "proven but undeveloped reserves" at the time of acquisition, that are economically beneficial and fit well into Treaty's program, but not strategic to large exploration-oriented oil and gas companies. This strategy provides Treaty with the proven assets to develop and produce oil and natural gas with tremendously decreased risk, cost and time involved in traditional exploration. For more information go to: www.treatyenergy.com
Forward-Looking Statements:
Statements herein express management's beliefs and expectations regarding future performance and are forward-looking and involve risks and uncertainties, including, but not limited to, raising working capital and securing other financing; responding to competition and rapidly changing technology; and other risks. These risks are detailed in the Company's filings with the Securities and Exchange Commission, including Forms SB-2, 10-KSB, 10-QSB and 8-K. Actual results may differ materially from such forward-looking statements.
Contact:
Investor Relations
Tel: 732-292-0982
Fax: 732-528-9065
investors@treatyenergy.com
Bostwick-Braun and Moore-Handley Sign Asset Purchase Agreement
Bostwick-Braun and Moore-Handley Sign Asset Purchase Agreement
Sep. 2, 2009 (GlobeNewswire) --
BIRMINGHAM, Ala., Sept. 2, 2009 (GLOBE NEWSWIRE) -- The Bostwick-Braun Company and Moore-Handley, Inc. (Pink Sheets:MHCO) announced today that they have signed an Asset Purchase Agreement with respect to the proposed sale of substantially all of the assets of Moore-Handley and its wholly-owned subsidiary, Hardware House, Inc., to Bostwick-Braun. The transaction remains subject to the approval of the U.S. Bankruptcy Court for the Northern District of Alabama, which will oversee an auction process that is designed to assure that the assets of Moore-Handley and Hardware House are sold for the highest and best price available.
Bostwick-Braun has stated that, if it is successful at the auction, Moore-Handley and Hardware House will continue to go to market under their current names, with their business being operated out of the Pelham, Alabama facility.
Moore-Handley, Inc., founded in 1882, is a large, regional hardware and building materials distributor headquartered in Pelham, Alabama. It is a full service distributor that provides its customers with competitive programs from over 1,000 major manufacturers including categories in plumbing and electrical supplies, power and hand tools, paint and paint sundries, lawn and garden equipment and building materials. Moore-Handley also offers its customers a diverse range of services such as marketing and advertising with support services including computer generated systems for the control of inventory, pricing and gross margin, store installation and design services.
"The company (Moore-Handley, Inc.) has great people and a very loyal customer base, just like we do. Moore-Handley's product mix is more building material/commodity oriented than ours, so customers of both companies will benefit from a wider selection of vendors and items. As we bring these two great organizations together, taking the best from each to strengthen the other, we're confident that we can truly make one plus one equal THREE!" --- William R. Bollin, Chairman-CEO, The Bostwick-Braun Company
The Bostwick-Braun Company, headquartered in downtown Toledo, Ohio, is a wholesale hardware distributor and industrial supplier. Established in 1855, it is the city's second oldest business. Bostwick-Braun has distribution centers located in Ashley, Indiana, McKeesport, Pennsylvania and Avon, Ohio.
CONTACT: Moore-Handley, Inc. Marleen Hering (205) 663-8209
Biotricity Corporation: Wood You Like Green Electricity?
Biotricity Corporation: Wood You Like Green Electricity?
Sep. 2, 2009 (GlobeNewswire) --
HOUSTON, Sept. 2, 2009 (GLOBE NEWSWIRE) -- Biotricity Corporation (Pink Sheets:GWND) announces that last week, headlines in the Wall Street Journal screamed that high-tech green energy is struggling to compete with traditional fuels. Ethanol, cellulosic fuels and biodiesel have all run into strategic business model barriers.
The popular path to alternative energy in America has not been well thought out. Two weaknesses have emerged. First, most green fuels are derived from feedstocks that trade as volatile commodities, such as soy beans and corn; and second, most green fuels depend on new technologies that use overly complex, capital intensive processes that have rendered most biofuels projects uneconomical.
Biotricity is on a path less taken, and that makes all the difference.
Biotricity's technology can take raw waste products such as sawdust, wood chips, corn stover or begasse and convert them directly into electricity. Our feedstocks are abundant and cheap, and our estimated future cash flow compared to capital costs exhibits a far superior return on capital invested. By keeping our feedstock costs relatively low, we plan to produce green power faster and cheaper than our competitors.
"At Biotricity, we believe America needs practical solutions to generating its energy at home in order to reduce our enormous dependence on foreign imports," stated Tyson Rohde, CEO. "Many ethanol and biodiesel processes make for an interesting story, but often don't make sense with current economic conditions," he added. Biotricity has developed a new combustion technology for the burning of woody biomass to generate electricity to address America's growing demand for green power. Biotricity will generate green power from renewable energy sources and expects to reduce carbon emissions that would otherwise result from the natural decay of the biomass it burns. The Company is designing a proprietary Biotricity Power Generator to produce electricity from biomass such as wood chips, sawdust, waste paper, and other organic matter by processing biomass and burning it in a soon to be patented combustion chamber to power a turbine and generate electricity.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success.
CONTACT: Biotricity Corporation Chet Gutowsky, CFO (713) 984-7551 info@biotricitypower.com www.biotricitypower.com
IR and CEO contact information.
The Lyric Business Centre
440 Louisiana - Suite 1400
Houston, TX 77002
Tel: 713-425-5377
Fax: 713-425-5378
Email: Rnewton@treatyenergy.com
Investor Relations:
Tel: 732 292 0982
Fax: 732-528-9065
Email: investors@treatyenergy.com
WOW wrong once again sundevilfan according to their filings they are NOT diluting, show me where you can see the filings of a pink that shows they are not diluting.
Wow what a day. Would definately like to see this to start hammering away at the .018s again. Maybe it was the people buying yesterday ;) who knows
Hey mick, i noticed you were a mod on the teco board. Could you post that chart on there and sticky note it. It has alot of good information on it!! Thanks chi
I believe the ibox is correct...
Share Structure
Authorized Shares 500,000,000 shares
Outstanding Shares as of July 24, 2009, was 460,110,701
Most of the float locked up under restriction...
We had some nice volume going off at .018, i would really like to see a few million share days in a row of buying pressure.
TECO 1 left now at .018
TECO 1 left now at .018
TECO volume keeps rolling in at .018!!!
First of all, refrain from posting the same message more than 2 times, its considered spam. Second, sell according to level 2. Everyone says "sell and buy at the ask" but sometimes you cant, so you will have take a little bit of hit if you sell at the bid, but if level 2 only shows one on the bid and you own alot of shares, then you are kind of out of luck and then you become the new ask.
Check out TECO-Treaty Energy
TECO- Lots of buys coming in at .018
Lets close even folks
Some buys coming in at .018
VoX Communications Now Serving Predictive Dialing Businesses
Sep. 1, 2009 (U.S. Equity News) --
VoX Communications Corp, a leading provider of wholesale Voice over Internet Protocol (VoIP) telephone services, is now providing VoIP services to call centers that utilize predictive dialing services. Unlike many carriers that charge additional fees for short-duration calls, VoX does not add a surcharge, and is encouraging entities that use VoIP services with dialers to contact VoX for a price quote and a trial.
VoX's CEO, Paul Riss, noted, "We have signed up 10 dialer companies in the month of August and we believe we will be adding 10 more dialers in September. We are welcoming any size account, and at this point, our largest dialer customer is generating VoIP usage of $700 a day. The call center can be anywhere. For example, we are servicing a 40-seat call center in the Dominican Republic, a call center in Puerto Rico, and several US-based companies that use a predictive dialer. Some of these centers need to make thousands of calls per hour, and our robust VoIP offering is able to handle numerous concurrent calls with ease. We have significant capacity for these customers, and several of them have turned up in one day. We encourage interested companies to contact our CIO, Mark Richards, via email at mrichards@voxcorp.net."
"We anticipate our total billings in August will be approximately 15% higher than July billings, even though most of these dialer accounts turned up in the middle of the month," continued Riss. "In addition to the new dialer accounts, we have expanded our relationship with Melaleuca, Inc. to now target not just its Puerto Rico members, but also its US and Canadian members, to purchase our VoIP services. Furthermore, as we noted in our Quarterly Report on Form 10-Q for the quarterly period ended May 31, 2009, we continue to believe that we will have significant mobile VoIP revenues in our fourth quarter. Many new revenue sources have been coming to VoX, and we are very excited about the potential growth."
About VoX Communications
VoX Communications Corp., a wholly-owned subsidiary of Pervasip Corp. (OTCBB: PVSP), delivers wholesale voice over IP (VoIP) telephone services for the residential and small business markets. Leveraging a nationwide VoIP network and internally developed proprietary software and product features, VoX offers a private-label digital voice program sold to cable operators, cell phone carriers, WiMax carriers, CLECs, ISPs and resellers. VoX differentiates itself through a unique combination of high quality voice services, flexible back-office capabilities and automated provisioning systems that enable a quick turn-up for service providers and business entities, such as call centers. It offers a feature-rich, low-cost, high-quality alternative to traditional phone services. In addition, VoX offers carrier-type services for voice origination and termination, as well as toll-free and other IP-based services. For more information, please visit www.voxcorp.net.
Forward-looking statements: This release contains forward-looking statements that involve risks and uncertainties. Pervasip's actual results may differ materially from the results discussed in the forward-looking statements. Factors that might cause such a difference include, among others, certain risks and uncertainties over which the company may have no control. For further discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see the discussions contained in Pervasip's Annual Report on Form 10-KSB for the year ended November 30, 2008 and any subsequent SEC filings.
Contact: PERVASIP: Paul H. Riss Chief Executive Officer Ph: 212-404-7633 phriss@pervasip.com
Contact: U.S. Equity News Tel: (626) 961-8039 Email: info@usequitynews.com
Del Global Technologies Corporation Names John J. Quicke Interim CEO
Sep. 1, 2009 (Business Wire) -- Del Global Technologies Corp. (OTCBB: DGTC) ("Del Global" or "the Company") today announced that John J. Quicke will become the Interim CEO of the Company effective September 1. Mr. Quicke will succeed James A. Risher the current CEO. Mr. Risher will remain as a director of the company. Mr. Risher was named interim CEO in July, 2006 and appointed CEO on September 1, 2006.
John J. Quicke has extensive management experience and served as a director, President and COO of Sequa Corporation, a diversified industrial company, from 1993 until March 2004, and Vice Chairman and Executive Officer from March 2004 until March 2005. At Sequa, Mr. Quicke was responsible for the Automotive, Metal Coating, Specialty Chemicals, Industrial Machinery and Other Product operating segments of the company. Mr. Quicke has served as an Operating Partner of Steel Partners, Ltd. since September 2005 and as a Managing Director of Steel Partners LLC since December 2007. Steel Partners is the largest shareholder in Del Global Technologies Corp. He is also currently a director of Adaptec, Inc. (ADPT), Rowan Companies Inc. (RDC), WHX Corporation (WXCO) and Chairman of Collins Industries a subsidiary of BNS Holding Inc. (BNSSA). John’s operational expertise has been in leading a team-based approach through Operational Excellence Programs, including Lean Manufacturing, Six Sigma, Design for Six Sigma and Strategy Deployment.
ABOUT DEL GLOBAL TECHNOLOGIES CORP.
Del Global Technologies Corp. is primarily engaged in the design, manufacture and marketing of high performance diagnostic imaging systems for medical, dental and veterinary applications through the Del Medical Systems Group. Through its U.S. based Del Medical Imaging Corp. and Milan, Italy based Villa Sistemi Medicali S.p.A. subsidiaries the Company offers a broad portfolio of general radiographic, radiographic/fluoroscopic, portable x-ray and digital radiographic systems to the global marketplace. Through its RFI subsidiary, Del Global manufactures proprietary high voltage power conversion subsystems including electronic filters, high voltage capacitors, pulse modulators, transformers and reactors, and a variety of other products designed for industrial, medical, military and other commercial applications. The company's web site is www.delglobal.com.
Source: Business Wire (September 1, 2009 - 12:42 PM EDT)
News by QuoteMedia
Emisphere Technologies to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
Emisphere Technologies to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
Sep. 1, 2009 (Business Wire) -- Emisphere Technologies, Inc. (OTC BB: EMIS), a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical compounds using its Eligen® Technology, today announced that President and Chief Executive Officer, Michael V. Novinski, will present at Rodman & Renshaw’s 11th Annual Healthcare Conference at 11:40 AM EDT on Wednesday, September 9, 2009 in the Henry Salon on the 5th Floor of the New York Palace Hotel in New York City.
The Company’s presentation will be available via webcast and can be accessed at: http://www.wsw.com/webcast/rrshq15/emis or on the Company’s website, http://www.emisphere.com.
About Emisphere Technologies, Inc.
Emisphere is a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules or nutritional supplements using its Eligen® Technology. These molecules and compounds could be currently available or in development. Such molecules are usually delivered by injection; in many cases, their benefits are limited due to poor bioavailability, slow on-set of action or variable absorption. The Eligen® Technology can be applied to the oral route of administration as well other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal or transdermal. The company’s website is: www.emisphere.com.
Safe Harbor Statement Regarding Forward-looking Statements
The statements in this release and oral statements made by representatives of Emisphere relating to matters that are not historical facts (including without limitation those regarding the timing or potential outcomes of research collaborations or clinical trials, any market that might develop for any of Emisphere's product candidates and the sufficiency of Emisphere's cash and other capital resources) are forward-looking statements that involve risks and uncertainties, including, but not limited to, the likelihood that future research will prove successful, the likelihood that any product in the research pipeline will receive regulatory approval in the United States or abroad, the ability of Emisphere and/or its partners to develop, manufacture and commercialize products using Emisphere's drug delivery technology, Emisphere's ability to fund such efforts with or without partners, and other risks and uncertainties detailed in Emisphere's filings with the Securities and Exchange Commission, including those factors discussed under the caption "Risk Factors" in Emisphere's Annual Report on Form 10-K (file no. 000-17758) filed on March 16, 2009.
Source: Business Wire (September 1, 2009 - 12:55 PM EDT
nFinanSe Inc. Raises $12.2 Million In Equity Transactions
Sep. 1, 2009 (Business Wire) -- nFinanSe Inc. (OTCBB:NFSE) (www.nfinanse.com) today announced that the Company has completed aggregate equity offerings totaling $12.2 million through the $6.5 million sale of approximately 2.2 million shares of its Series D Convertible Preferred Stock and through the exchange of $5.7 million of notes and accrued interest for approximately 1.9 million shares of Series D Convertible Preferred Stock. Each share of the Series D Convertible Preferred Stock is convertible into ten shares of the Company’s common stock at $0.30 per share. Each investor received warrants to purchase 10 shares of common stock at $0.01 per share for each share of Series D Convertible Preferred Stock.
Additionally, those Series D investors who invested an amount equal to or greater than 25% of the amounts invested in prior transactions involving stock or certain Accommodation Loans and Term Loans had the exercise price of any Company warrants held by such Series D investor reduced to (i) $0.30 per share of common stock, if they invested $100,000 or more or (ii) $0.01 per share of common stock, if they invested $250,000 or more.
Jerry R. Welch, Chairman and Chief Executive Officer, said, “Through these equity transactions, we have provided significant cash and equity to the Company and substantially improved our financial position. The prepaid card industry is still in the early stages of development and maintaining a solid balance sheet will be important for our Company as we participate in the industry’s growth.”
The Company had previously reported on its SEC filings that on August 21, 2009 it had closed on $10.9 million of equity through a $5.2 million sale and a $5.7 million exchange for notes. During the past 10 days, the Company said it sold an additional $1.3 million of its Series D Convertible Preferred Stock.
Emerging Growth Equities, Ltd. acted as placement agent for the offering.
About nFinanSe Inc.
nFinanSe Inc. (OTC BB: NFSE) is an innovative financial services company and provider of stored value and prepaid card solutions headquartered in Tampa, Florida. nFinanSe has developed the nFinanSe Network™, a secure, reliable value load and activation platform that connects with retail merchants and other value load stations located throughout the United States. For more information, visit www.nfinanse.com.
“Safe Harbor” Statement under Private Securities Litigation Reform Act of 1995
This press release contains certain forward-looking statements based on nFinanSe Inc.’s, or, the Company’s current expectations, forecasts and assumptions that involve risks and uncertainties. Forward-looking statements include statements regarding the Company’s expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “will,” and “would” or similar words and include statements regarding the anticipated benefits of the Company’s products and the anticipated retail roll out of the Company’s products. Forward-looking statements in this release are based on information available to the Company as of the date hereof. The Company’s actual results may differ materially from those stated or implied in such forward-looking statements due to risks and uncertainties associated with the Company’s business, which include the Company’s ability to execute its business strategy and the other risk factors disclosed in the Annual Report on Form 10-K for the year ended January 3, 2009 on file with the Securities and Exchange Commission. The Company assumes no obligation to update the information included in this press release, whether as a result of new information, future events or otherwise.
Either am I but I do know that if the chart is set up correctly it could be a huge run.
I picked up some more today. Banking on that happening.
Wow, Treaty moved on less than 10k in volume. I am curious to see what the float is.
IFSL has huge volume and just hit a penny WOW
There is alot of bid support at .2105 according to level 2.